TrialBlood advances2018

Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial).

Ahmed A Daak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.